Our recipe for success lies in our experience of hundreds of happy patients who have achieved their goals of weight loss because of our patient centered approach
Men or women who might benefit from fat transfer include those who have age-related facial atrophy, those who have had filler treatments and now want a permanent option, and those whose facial structure is deficient in certain areas where volume and contour are important (such as cheekbones, jawline, chin, lips, temples and eye sockets)
No fumbling with oversized syringes
Targeted biologic therapies under evaluation for SLE include anifrolumab, belimumab (intravenous and subcutaneous formulations were registered by FDA for use in SLE in 2017) and off-label rituximab, abatacept, tocilizumab, obintuzumab, and eculizumab.[3] The novel biologic therapy, telitacicept, is currently under investigation